Combined chemotherapy, protocol MACOP-B, was administered to 21 patients with non-Hodgkin lymphoma (NHL) with a medium or high grade of malignity, clinical stage II-IV. Complete remission was achieved in 17 patients (81%), in one instance partial remission was induced. One patient died from a cardiovascular and one from a thromboembolic complication during treatment. In one patient the results were not evaluated. Three patients developed severe granulocytopenia which called for reduction or delay of treatment and a septic condition developed. In addition to myelosuppression the main complications were stomatitis and mycosis. No death caused by infectious or haemorrhagic complications was recorded. The described chemotherapy is recommended in particular in immunoblastic lymphomas, diffuse lymphomas from cleaved and non-cleaved cells and diffuse lymphomas with mixed cellularity.

Keywords: Adult; Antineoplastic Combined Chemotherapy Protocols /therapeutic use/; Bleomycin /administration & dosage/; Cyclophosphamide /administration & dosage/; Doxorubicin /administration & dosage/; Female; Humans; Leucovorin /administration & dosage/; Lymphoma, Non-Hodgkin /drug therapy/; Male; Methotrexate /administration & dosage/; Middle Aged; Prednisone /administration & dosage/; Vincristine /administration & dosage/